Novartis AG
NVS
Company Profile
Business description
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
Contact
Lichtstrasse 35
Basel4056
CHET: +41 613241111
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
76,057
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,567.00 | 12.10 | -0.14% |
CAC 40 | 7,213.32 | 14.87 | 0.21% |
DAX 40 | 19,146.17 | 141.39 | 0.74% |
Dow JONES (US) | 43,948.27 | 539.80 | 1.24% |
FTSE 100 | 8,149.27 | 64.20 | 0.79% |
HKSE | 19,601.11 | 103.90 | -0.53% |
NASDAQ | 19,025.44 | 59.30 | 0.31% |
Nikkei 225 | 38,026.17 | 326.17 | -0.85% |
NZX 50 Index | 12,765.24 | 28.18 | 0.22% |
S&P 500 | 5,960.78 | 43.67 | 0.74% |
S&P/ASX 200 | 8,323.00 | 3.30 | -0.04% |
SSE Composite Index | 3,370.40 | 2.41 | 0.07% |